Exploring Neuroscience, Psychiatry, & Rare Diseases, Bruce Leuchter, President & CEO, Neurvati
Synopsis: In this episode of Biotech 2050, host Alok Tayi, CEO and co-founder of Vibe Bio, speaks with Dr. Bruce Leuchter, President and CEO of Neurvati Neuroscience. They discuss capital markets, n...
13 Jun 202451min
Transformative Oncology Innovations, Ken Keller, President & CEO, Daiichi Sankyo, Inc.
Synopsis: In this episode of BioTech 2050, Ken Keller, President and CEO of Daiichi Sankyo, Inc. provides an in-depth look into the company's transformation from a cardiovascular-focused organizatio...
6 Jun 202428min
Strategic Leadership and Autoimmune Breakthroughs, Praveen Tipimeni, CEO
Synopsis: In this episode of Biotech2050, Praveen Tipirneni, CEO of Morphic Therapeutics, shares insights on Morphic’s strategic IPO, the rising interest in autoimmune treatments, the journey of thei...
23 Mai 202434min
Innovative Approaches to Cancer Therapies, Robert Ang, President and CEO
Synopsis: In this episode of BioTech 2050, Robert Ang, CEO of Vor Bio, shares insights on the current state of cancer therapies and next-gen modalities. He discusses Vor Bio's work on shielded stem ...
15 Mai 202430min
Tech-Biotech Convergence, Growth, and Global Lessons, Vik Bajaj, Co-founder and CEO
Synopsis: In this episode of Biotech2050, Vik Bajaj, Co-founder and CEO of Foresite Labs, delves into the convergence of tech and biotech, hyper-growth phases in biotech companies, changes in financ...
8 Mai 202431min
Advancing and Revolutionizing Sickle Cell Treatment, Ted Love, Chair and BOD
Synopsis: In this episode of Biotech2050, Dr. Ted Love, former CEO of Global Blood Therapeutics and Current Chairman of BIO, shares insights on sickle cell breakthroughs, transitioning from academia ...
2 Mai 202427min
Demystifying Drug Discovery, Ray Stevens, CEO, Structure Therapeutics
Synopsis: In this episode of the Biotech 2050 podcast, host Rahul Chaturvedi engages in a thought-provoking conversation with Ray Stevens, a prominent figure in the biotech industry who co-founded St...
3 Apr 202431min
Navigating The Evolving Landscape of Inflammation Research, Scott Megaffin, CEO, Adiso Therapeutics
Synopsis: In this episode of Biotech2050, Scott Megaffin, CEO of Adiso Therapeutics, shares valuable insights on the challenges and opportunities in the biotech industry. His deep involvement in the ...
27 Mar 202427min
